• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

ABT-492对厌氧菌的体外活性。

In vitro activity of ABT-492 against anaerobic bacteria.

作者信息

Sillerström E, Wahlund E, Nord C E

机构信息

Division of Clinical Bacteriology, Department of Laboratory Medicine, Karolinska Institute, Karolinska University Hospital Huddinge, Stockholm, Sweden.

出版信息

J Chemother. 2004 Jun;16(3):227-9. doi: 10.1179/joc.2004.16.3.227.

DOI:10.1179/joc.2004.16.3.227
PMID:15330316
Abstract

The purpose of the study was to determine the in vitro activity of ABT-492 compared with that of other antimicrobial agents against anaerobic bacteria. The activity of ABT-492 was investigated against 369 clinical isolates of anaerobic bacteria by the agar dilution method and was compared with that of moxifloxacin, piperacillin, cefoxitin, imipenem, clindamycin and metronidazole. ABT-492 and imipenem were the most active antimicrobial agents tested.

摘要

本研究的目的是确定ABT - 492与其他抗菌药物相比对厌氧菌的体外活性。采用琼脂稀释法研究了ABT - 492对369株临床分离厌氧菌的活性,并与莫西沙星、哌拉西林、头孢西丁、亚胺培南、克林霉素和甲硝唑进行了比较。ABT - 492和亚胺培南是测试中活性最强的抗菌药物。

相似文献

1
In vitro activity of ABT-492 against anaerobic bacteria.ABT-492对厌氧菌的体外活性。
J Chemother. 2004 Jun;16(3):227-9. doi: 10.1179/joc.2004.16.3.227.
2
Comparative in vitro antimicrobial activity of a novel quinolone, garenoxacin, against aerobic and anaerobic microbial isolates recovered from general, vascular, cardiothoracic and otolaryngologic surgical patients.新型喹诺酮类药物加替沙星对从普通外科、血管外科、心胸外科和耳鼻喉科手术患者中分离出的需氧和厌氧微生物菌株的体外抗菌活性比较
J Antimicrob Chemother. 2005 Nov;56(5):872-8. doi: 10.1093/jac/dki348. Epub 2005 Sep 26.
3
In vitro activity of quinolones and other antimicrobial agents against anaerobic bacteria.喹诺酮类及其他抗菌药物对厌氧菌的体外活性
Clin Infect Dis. 1996 Dec;23 Suppl 1:S15-8. doi: 10.1093/clinids/23.supplement_1.s15.
4
In vitro activity of the new quinolone BAY y 3118 against anaerobic bacteria.新型喹诺酮BAY y 3118对厌氧菌的体外活性
Eur J Clin Microbiol Infect Dis. 1993 Aug;12(8):640-2. doi: 10.1007/BF01973648.
5
In vitro activity of ABT-773 against anaerobic bacteria.
Eur J Clin Microbiol Infect Dis. 2000 Aug;19(8):635-7. doi: 10.1007/s100960000337.
6
["In vitro" activity of ten antimicrobial agents against anaerobic bacteria. A collaborative study, 1999-2002].十种抗菌药物对厌氧菌的“体外”活性。一项合作研究,1999 - 2002年
Rev Argent Microbiol. 2004 Jul-Sep;36(3):130-5.
7
In vitro activity of BAY y 3118, and nine other antimicrobial agents against anaerobic bacteria.BAY y 3118及其他九种抗菌剂对厌氧菌的体外活性。
J Chemother. 1995 Jun;7(3):189-96. doi: 10.1179/joc.1995.7.3.189.
8
Susceptibility of anaerobic bacteria to tosufloxacin.厌氧菌对妥舒沙星的敏感性。
Eur J Clin Microbiol Infect Dis. 1992 Mar;11(3):263-5. doi: 10.1007/BF02098095.
9
Antianaerobic activity of a novel fluoroquinolone, WCK 771, compared to those of nine other agents.新型氟喹诺酮类药物WCK 771与其他九种药物的抗厌氧活性比较。
Antimicrob Agents Chemother. 2004 Aug;48(8):3188-92. doi: 10.1128/AAC.48.8.3188-3192.2004.
10
Susceptibility of anaerobic bacteria to PD 131628.厌氧菌对PD 131628的敏感性。
Eur J Clin Microbiol Infect Dis. 1992 Jan;11(1):68-71. doi: 10.1007/BF01971277.

引用本文的文献

1
Delafloxacin: Place in Therapy and Review of Microbiologic, Clinical and Pharmacologic Properties.达氟沙星:在治疗中的地位以及微生物学、临床和药理学特性综述
Infect Dis Ther. 2018 Jun;7(2):197-217. doi: 10.1007/s40121-018-0198-x. Epub 2018 Mar 31.
2
Moxifloxacin in the treatment of skin and skin structure infections.莫西沙星治疗皮肤和皮肤结构感染。
Ther Clin Risk Manag. 2006 Dec;2(4):417-34. doi: 10.2147/tcrm.2006.2.4.417.